CDSCO has granted marketing authorisation for Qdenga®, India’s first approved dengue vaccine, for individuals aged 4–60 years. The approval creates new commercialisation and compliance priorities for the importer, distributors, healthcare providers and pharmaceutical supply-chain partners.